BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 14, 2011
View Archived Issues
New phase I/II data on vector-based malaria vaccines
Read More
Preclinical data support advancement of new Servier product to clinic
Read More
Intellikine divulges preclinical data on INK-1117
Read More
New phosphodiesterase 10A inhibitors claimed
Read More
Novel serine/threonine-protein kinase ATR inhibitors prepared by Vertex
Read More
Belgian authorities clear phase I/II combination treatment study in metastatic melanoma
Read More
FDA grants standard review status for carfilzomib NDA
Read More
First data reported on Graspa in older patients with Ph- ALL
Read More
CSF-1-R-targeted antibody shows promise in proof-of-principle study
Read More
Pharmaxis reaches recruitment target in Bronchitol trial
Read More
Arcarios receives loan to develop osteoarthritis drug candidate
Read More
Chinese organizations patent new anticancer agents
Read More
Anacor Pharmaceuticals reports phase IIa data on AN-2728 and AN-2898
Read More
Novel pancreatic cancer vaccine enters clinic
Read More
Ablynx and Merck Serono select Nanobody for preclinical development
Read More
Celladon heart failure therapy receives FDA fast track status
Read More
Genentech begins first-in-human study of IL-17-directed antibody
Read More
Geron begins phase II study of GRN-1005
Read More
New inhibitors of cytokine signaling designed in U.S.
Read More
Eisai reports new agents with antitumor potential
Read More
MicroRNA therapeutics discovery effort begins in glioblastoma multiforme
Read More
Novel histamine H3 receptor antagonists/inverse agonists reported
Read More
Repros Therapeutics reports topline data on Androxal in hypogonadism and type 2 diabetes
Read More
Cubist Pharmaceuticals acquires Adolor
Read More
Transition Therapeutics begins phase I TT-401 trial
Read More